SCHEMBL6933398

SCHEMBL6933398

NCCCCCOP(O)(O)=S

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 14/20 0.61
LPAR2 Q9HBW0 11/20 0.61
LPAR1 Q92633 8/20 0.50
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA3 P07451 2/20 0.38
CA4 P22748 2/20 0.38
CA6 P23280 2/20 0.38
CA5A P35218 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
DNM1 Q05193 1/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
BLM P54132 1/20 0.38
LPAR6 P43657 3/20 0.38
LPAR4 Q99677 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25559472 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1CA12CA1
SCHEMBL13748550 0.82 LPAR3 (0.47) LPAR3LPAR2LPAR1CA12CA1
SCHEMBL11300901 0.80 DNM1 (0.42) LPAR3LPAR2CA12CA1CA2
SCHEMBL3501699 0.79
SCHEMBL12819009 0.79 LPAR3 (0.44) LPAR3LPAR2LPAR1CA12CA1
SCHEMBL5585483 0.77
SCHEMBL23631720 0.76 ITPR3 (0.47) LPAR3LPAR2LPAR1CA12CA1
SCHEMBL4521470 0.76 LPAR3 (0.61) LPAR3LPAR2LPAR1CA12CA1
SCHEMBL4529975 0.76 LPAR3 (0.61) LPAR3LPAR2LPAR1CA12CA1
SCHEMBL8657418 0.76 LPAR3 (1.00) LPAR3LPAR2LPAR1LPAR6LPAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-56034692-A None JP disclosed
JP-55139393-A None JP disclosed
EP-1368038-A1 METHODS FOR THE ADMINISTRATION OF AMIFOSTINE AND RELATED COMPOUNDS Medimmune Oncology, Inc. (US) 2003-12-10 EP disclosed
WO-2002062350-A1 METHODS FOR THE ADMINISTRATION OF AMIFOSTINE AND RELATED COMPOUNDS MEDIMMUNE ONCOLOGY, INC. (US) 2002-08-15 WO disclosed
EP-1007055-A4 METHODS FOR THE ADMINISTRATION OF AMIFOSTINE MEDIMMUNE ONCOLOGY INC (US) 2002-05-29 EP disclosed
EP-1007055-A1 METHODS FOR THE ADMINISTRATION OF AMIFOSTINE U.S. BIOSCIENCE, INC. (US) 2000-06-14 EP disclosed
WO-1998034622-A1 METHODS FOR THE ADMINISTRATION OF AMIFOSTINE U.S. BIOSCIENCE, INC. (US) 1998-08-13 WO disclosed
US-4279838-A HYDROLYZING AN N-ACETYLAMINOARYL THIOPHOSPHATE OR PHOSPHATE MITSUI TOATSU CHEMICALS INC. (JP) 1981-07-21 US disclosed
US-4279838-A HYDROLYZING AN N-ACETYLAMINOARYL THIOPHOSPHATE OR PHOSPHATE MITSUI TOATSU CHEMICALS INC. (JP) 1981-07-21 US disclosed
JP-S5634692-A PREPARATION OF AMINOARYL THIOPHOSPHATE OR PHOSPHATE MITSUI TOATSU CHEM INC 1981-04-06 JP disclosed
JP-S55139393-A PRODUCTION OF AMINOARYL PHOSPHATE OR AMINOARYL THIOPHOSPHATE MITSUI TOATSU CHEM INC 1980-10-31 JP disclosed